🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The hope is that the peptide vaccines will stimulate the immune system to a...
Status
Completed
Location
University of Arkansas for Medical Sciences/MIRT
Start Date
2004-06
Trial ID
NCT00090493
Treatments Being Tested
This is a double-blind study in which approximately 99 study patients will ...
Status
Unknown
Location
Disney Family Cancer Center
Start Date
2017-11-18
Trial ID
NCT02033616
This is an open label, single-arm, phase IB treatment study to determine th...
Status
Unknown
Location
Jericho Rabago
Start Date
2021-04-21
Trial ID
NCT03743298
Treatments Being Tested
This study is an open-label, pilot study of an autologous tumor cell vaccin...
Status
Completed
Location
University of Virginia
Start Date
2000-05-01
Trial ID
NCT00912418
Treatments Being Tested
RATIONALE: Vaccines made from a person's cancer cells may make the body bui...
Status
Terminated
Location
University of Nebraska Medical Center
Start Date
2000-10-11
Trial ID
NCT00006478
Treatments Being Tested
The purpose of this trial is to assess the immune response after vaccinatio...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2013-04
Trial ID
NCT01827137
Treatments Being Tested
This single-arm phase II study will assess the impact of tetanus pre-condit...
Status
Terminated
Location
Duke University Medical Center
Start Date
2019-09-30
Trial ID
NCT03927222
RATIONALE: Vaccines made from a person's tumor cells and white blood cells ...
Status
Completed
Location
Hoag Cancer Institute at Hoag Memorial Hospital Presbyterian
Start Date
2006-12
Trial ID
NCT00436930
Treatments Being Tested
This is a single-arm, open-label phase II clinical trial in which approxima...
Status
Unknown
Location
Scripps Health
Start Date
2018-06-20
Trial ID
NCT03400917
Treatments Being Tested
This study will examine whether vaccination with a p53 peptide can boost an...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
1999-07-26
Trial ID
NCT00001827